Answer
Tocilizumab binds specifically to both soluble and membrane-bound interleukin-6 receptors (sIL‑6R and mIL‑6R) and inhibits signalling mediated by both receptors.
Sources for this answer
- RoActemra 20mg/ml Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 38Document updated
Sources checked